title: I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases.
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Yamamoto
authors.affiliation: 1] Department of Hematology, Toranomon Hospital, Tokyo, Japan [2] Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Uchida
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Matsuno
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Kon
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Nishida
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Ota
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Ikebe
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Nakano
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Ishiwata
authors.affiliation: Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Araoka
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Takagi
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Tsuji
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Asano-Mori
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: G
authors.initials: G
authors.lastname: Yamamoto
authors.affiliation: 1] Department of Hematology, Toranomon Hospital, Tokyo, Japan [2] Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Izutsu
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Masuoka
authors.affiliation: Department of Hematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Wake
authors.affiliation: Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Yoneyama
authors.affiliation: Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Makino
authors.affiliation: 1] Department of Hematology, Toranomon Hospital, Tokyo, Japan [2] Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Taniguchi
mesh_terms: D000328:Adult; D000368:Aged; D002066:Busulfan / Q000008:administration & dosage*; D036101:Cord Blood Stem Cell Transplantation; D018572:Disease-Free Survival; D005260:Female; D006402:Hematologic Diseases / Q000401:mortality / Q000628:therapy; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage*; D008875:Middle Aged; D012307:Risk Factors; D015996:Survival Rate; D019172:Transplantation Conditioning; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014916:Whole-Body Irradiation
chemical_list: D014740:Vidarabine; D002066:Busulfan; C024352:fludarabine; D008558:Melphalan